1. The Utilization of Low Dose Naltrexone for Chronic Pain

   • Salomon Poliwoda
   • Bryant Noss
   • Omar Viswanath

   Current Opinion 28 July 2023 Pages: 663 - 670

2. Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease

   • Solana Leisher
   • Adriana Bohorquez
   • Michael S. Rafii

   Review Article Open access 20 July 2023 Pages: 671 - 677

   

3. GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder

   • Christopher Sikes-Keilp
   • David R. Rubinow

   Review Article 05 August 2023 Pages: 679 - 693

4. Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis

   • Qian Li
   • Xin Li
   • Tianmei Si

   Systematic Review Open access 25 July 2023 Pages: 695 - 713

   

5. Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study

   • Meredith Castro
   • Samuel T. Wilkinson
   • Patricia Cabrera

   Original Research Article Open access 09 August 2023 Pages: 715 - 723

   

6. Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment

   • Valentin Loser
   • Jan Novy
   • Andrea O. Rossetti

   Original Research Article Open access 19 July 2023 Pages: 725 - 731